Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
EnterprisewideAdd to Basket
Site LicenseAdd to Basket
Live Chat Live Help Software for Website

European IV Therapy and Enteral Nutrition Devices Markets

Frost & Sullivan, Sep 2009, Pages: 79


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

This research service examines the European IV therapy and enteral nutrition devices market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the market share analysis, the revenue forecasts and growth rates.

This Frost & Sullivan research service titled European IV Therapy and Enteral Nutrition Devices Market provides market drivers and restraints along with revenue forecasts and market share analysis. In this research, Frost & Sullivan's expert analysts thoroughly examine the following segments: catheters, infusion pumps, administration sets, feeding tubes and feeding pumps.

Market Overview

European IV Therapy and Enteral Nutrition Devices Market Presents Highly Dynamic Environment

The European IV therapy and enteral nutrition devices market currently offers a highly dynamic and lucrative environment. Advances in pharmacology and a wider range of blood products have substantially increased the number of possible drug therapies, which can be used with IV therapy devices. At the same time, developments in biotechnology are rapidly expanding the range of available blood products. “IV therapy devices companies are increasingly focussing on developing computer-aided design for their products, resulting in improved and more efficient coordination of procedures,” notes the analyst of this research. “Technological advances will not only make the procedures safer but also smarter and more efficient for both IV therapy and enteral nutrition devices.”

IV therapy can be administered at home for patients who do not necessarily need hospital care. European hospitals have recently enforced strict regulations which have resulted in the introduction of diagnostic related groups (DRGs). This approach focusses solely on downsizing and reducing the time spent by patients in hospitals. This trend has significantly raised the value of homecare in Europe. In a parallel development, it is now proven that IV therapy can be delivered safely and effectively in patients' homes. Homecare provides greater independence for patients along with cost saving benefits, ensuring a win-win situation.

Medical Devices Market Flexes its Muscle, Growth Set to Continue

A majority of the European IV therapy and enteral nutrition devices market is held by a few tier-one and tier-two participants. This highly concentrated market implies intense competition. Accordingly, market entry is difficult. This acts as a major restraint as potential participants are being driven out of the market. The end results are market stagnation and dynamism. “The declining prices of IV therapy and enteral devices are chiefly due to bulk purchases and tenders,” adds the analyst. “Often manufacturers bundle together products which results in slashing of prices.” It is not always possible for smaller companies to reduce their prices and hence, might lead to further market consolidation.

The medical devices sector has been on a bull run for the past few years, matching, if not frequently, exceeding growth expectations. Medical device companies grew their aggregate top line at an annual rate of 11.0 per cent. In the context of higher-end medical devices (which contribute substantially towards the total market revenue), physician’s ability to perform certain procedures is often linked to the device itself. Most of these devices are used in high-acuity setting and hence cannot be ignored. “Companies that manufacture devices to treat life-threatening conditions will continue to be immune to the recent economic tensions,” concludes the analyst. “Currently, the underlying demand for medical devices will lead to a comparatively smooth business cycle and the market will, in all probability, continue its strong lead.”

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following product segments in this research:

- Catheters
- Infusion pumps
- Administration sets
- Feeding tubes
- Feeding pumps


Product samples

A sample for this product is available. Please Login/Register to download this sample.

For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds